AnalystsSean McCutcheonSean McCutcheon's Stock Forecasts
AnalystsSean McCutcheon
Sectors:
Industries:
Analyst Ranking
Top 27%
#1492 out of 5511 analysts
Average Return
+23.87%
Win Rate
27%4 out of 15
Risk vs Reward
Poor
Good
Sean McCutcheon's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Revolution Medicines IncRVMD | +337.74% | $46.55 | $203.77 | 2025-09-12 - 2026-09-11 | Strong Buy |
Revolution Medicines IncRVMD | +278.67% | $54.10 | $204.86 | 2025-10-17 - 2026-09-15 | Strong Buy |
Vir Biotechnology IncVIR | +76.28% | $5.65 | $9.96 | 2025-07-11 - 2026-07-10 | Buy |
Faeth Therapeutics IncFTH | +29.85% | $27.24 | $35.37 | 2026-07-31 - 2026-09-15 | Buy |
Sean McCutcheon Analyst Color
Get additional color on Sean McCutcheon's coverage of popular stocks
Sean McCutcheon's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bridgebio Oncology Therapeutics IncBBOT | 2 | Buy | $22.00 | +350.82% | Maintains | 7 days ago |
Xencor IncXNCR | 2 | Strong Buy | $46.00 | +93.68% | Maintains | 15 days ago |
Faeth Therapeutics IncFTH | 1 | Buy | $56.00 | +58.33% | Initiates Coverage On | 2 months ago |
Revolution Medicines IncRVMD | 2 | Strong Buy | $76.00 | -62.90% | Maintains | a year ago |
Vir Biotechnology IncVIR | 1 | Buy | $12.00 | N/A | Initiates Coverage On | a year ago |
Janux Therapeutics IncJANX | 1 | Buy | $65.00 | N/A | Initiates Coverage On | a year ago |
Compass Therapeutics IncCMPX | 1 | Buy | $9.00 | N/A | Reinstates | a year ago |
Black Diamond Therapeutics IncBDTX | 1 | Buy | $11.00 | N/A | Reinstates | a year ago |
Engene Therapeutics IncENGN | 1 | Buy | $23.00 | N/A | Initiates Coverage On | 2 years ago |
Cytokinetics IncCYTK | 2 | Buy | $70.00 | N/A | Maintains | 2 years ago |
Legend Biotech CorpLEGN | 1 | Buy | $86.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.